Market Overview:
The global dextran 20 market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for dextran 20 in various applications such as hospitals, clinics, and others. Additionally, the growing awareness about the benefits of using dextran 20 is also contributing to the growth of this market.
Product Definition:
Dextran 20 is a water soluble, long chain glucose polymer. It has a molecular weight of about 2,000 daltons and is composed of 20 glucose monomers linked together. Dextran 20 has several important properties including viscosity enhancement, colloidal stabilization and blood volume expanders.
10g/100ml:
10g/100ml is a type of dextran which has molecular weight range from 200,000 to 2,000,000 Da. It's produced by the chemical reaction between amylose and glucosamine. The product is used as an adhesive for medical implants such as artificial joints and pacemakers.
It can also be used in wound dressings & surgeries or applied directly to burn injuries for rapid healing purposes.
25g/250ml:
25g/250ml is a standard packaging solution for dextran sulfate, which is used as an intravenous fluid in hospital settings. The 25g/250ml packaged dextran sulfate has a purity level of more than 95% and offers cost-effective storage and handling convenience to the end users. It can be easily stored at room temperature as it comes in flexible plastic bottles with flip cap closures.
Application Insights:
The hospital application segment led the global dextran 20 market in 2017 and is projected to maintain its dominance over the forecast period. The rising number of surgeries, increasing prevalence of chronic diseases and growing aging population are some of the major factors driving demand for intravenous fluids across hospitals globally. In addition, favorable government policies promoting infrastructure development in healthcare facilities that include infusion pumps are expected to drive demand for dextran 20 over the forecast period.
The others application segment includes surgical theaters, clinics and other medical centers that provide diagnostic or therapeutic services without admission or consultation at a patient¢â‚¬â„¢s home. Surgical theaters accounted for a significant share in 2017 owing to their high usage rate as an operating room during surgeries such as cosmetic procedures, knee & hip replacement surgery among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period owing to increasing demand for dextrans from various end-use industries, such as medical and healthcare, food and beverage, pharmaceuticals, cosmetics and personal care products. In addition, rising prevalence of chronic diseases coupled with growing awareness about product benefits are some other factors driving regional growth.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rapid developments in end-use industries along with expanding healthcare infrastructure facilities across emerging economies including China and India. Growing geriatric population coupled with an increase in lifestyle-associated diseases will also contribute toward regional demand for dextran 20 during the same period (2018 - 2030).
Growth Factors:
- Increasing demand for dextran 20 in the biopharmaceutical and medical industries for various applications such as cell culture, protein purification, and blood plasma volume expanders.
- Growing research on dextran 20 for use as a novel drug delivery system in cancer therapy.
- Rising demand from emerging markets due to increasing awareness about the benefits of dextran 20 products among consumers and healthcare professionals.
- Technological advancements that have led to the development of new applications for dextran 20 products in different industries such as food & beverage, personal care, and pharmaceuticals.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dextran 20 Market Research Report
By Type
10g/100ml, 25g/250ml, 50g/500ml, Others
By Application
Hospital, Clinic, Others
By Companies
Thermo Fisher, Nanocs, Mudanjiang Wanwei Pharmaceutical, Irvine Scientific, AAT, Merck, Xian Ruixi Biological, Aetna
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Dextran 20 Market Report Segments:
The global Dextran 20 market is segmented on the basis of:
Types
10g/100ml, 25g/250ml, 50g/500ml, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Nanocs
- Mudanjiang Wanwei Pharmaceutical
- Irvine Scientific
- AAT
- Merck
- Xian Ruixi Biological
- Aetna
Highlights of The Dextran 20 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10g/100ml
- 25g/250ml
- 50g/500ml
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dextran 20 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dextran 20 is a type of sugar molecule that is used as a blood thinner. It can help reduce the risk of blood clots, which can lead to serious health problems.
Some of the key players operating in the dextran 20 market are Thermo Fisher, Nanocs, Mudanjiang Wanwei Pharmaceutical, Irvine Scientific, AAT, Merck, Xian Ruixi Biological, Aetna.
The dextran 20 market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dextran 20 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dextran 20 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dextran 20 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dextran 20 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dextran 20 Market Size & Forecast, 2018-2028
4.5.1 Dextran 20 Market Size and Y-o-Y Growth
4.5.2 Dextran 20 Market Absolute $ Opportunity
Chapter 5 Global Dextran 20 Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dextran 20 Market Size Forecast by Type
5.2.1 10g/100ml
5.2.2 25g/250ml
5.2.3 50g/500ml
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dextran 20 Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dextran 20 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dextran 20 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dextran 20 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dextran 20 Analysis and Forecast
9.1 Introduction
9.2 North America Dextran 20 Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dextran 20 Market Size Forecast by Type
9.6.1 10g/100ml
9.6.2 25g/250ml
9.6.3 50g/500ml
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dextran 20 Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dextran 20 Analysis and Forecast
10.1 Introduction
10.2 Europe Dextran 20 Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dextran 20 Market Size Forecast by Type
10.6.1 10g/100ml
10.6.2 25g/250ml
10.6.3 50g/500ml
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dextran 20 Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dextran 20 Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dextran 20 Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dextran 20 Market Size Forecast by Type
11.6.1 10g/100ml
11.6.2 25g/250ml
11.6.3 50g/500ml
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dextran 20 Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dextran 20 Analysis and Forecast
12.1 Introduction
12.2 Latin America Dextran 20 Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dextran 20 Market Size Forecast by Type
12.6.1 10g/100ml
12.6.2 25g/250ml
12.6.3 50g/500ml
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dextran 20 Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dextran 20 Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dextran 20 Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dextran 20 Market Size Forecast by Type
13.6.1 10g/100ml
13.6.2 25g/250ml
13.6.3 50g/500ml
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dextran 20 Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dextran 20 Market: Competitive Dashboard
14.2 Global Dextran 20 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher
14.3.2 Nanocs
14.3.3 Mudanjiang Wanwei Pharmaceutical
14.3.4 Irvine Scientific
14.3.5 AAT
14.3.6 Merck
14.3.7 Xian Ruixi Biological
14.3.8 Aetna
